Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies

Anti-SARS-CoV2 mRNA vaccines showed a blunted antibody (Ab) response in people with MS (pwMS) on high efficacy therapies, suggesting the need for a booster dose. We evaluated the kinetics of the production of anti-receptor binding domain (RBD) Immunoglobulins G (IgG) after the vaccination cycle and...

Descripción completa

Detalles Bibliográficos
Autores principales: Maglione, Alessandro, Morra, Marta, Meroni, Raffaella, Matta, Manuela, Clerico, Marinella, Rolla, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957380/
https://www.ncbi.nlm.nih.gov/pubmed/35364386
http://dx.doi.org/10.1016/j.msard.2022.103776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957380/
https://www.ncbi.nlm.nih.gov/pubmed/35364386
http://dx.doi.org/10.1016/j.msard.2022.103776

Ejemplares similares